Related Experiment Videos
Hormone receptors in renal cancer: an overview
1Department of Urology, University of Innsbruck Medical School, Austria.
Abstract:
The current literature concerning hormone receptors in renal cell cancer is reviewed. Our own results of histochemical determination of estrogen receptors by means of monoclonal antibodies are presented. Based on the studies that have been reviewed and the differing results of the receptor assays, we conclude that there is a very limited basis to apply hormone therapy in renal cell cancer. However, the new immunohisto-chemical methods should be used to resolve the question about the hormone dependency of renal carcinoma.
Insights
Hormone receptors in renal cell cancer have limited evidence for hormone therapy. New immunohistochemical methods are needed to determine the hormone dependency of renal carcinoma.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Hormone receptors play a role in various cancers.
- The role of hormone receptors in renal cell carcinoma (RCC) remains incompletely understood.
- Previous studies on hormone receptors in RCC have yielded conflicting results.
Purpose of the Study:
- To review the current literature on hormone receptors in renal cell cancer.
- To present original findings on the histochemical determination of estrogen receptors in RCC using monoclonal antibodies.
- To evaluate the potential for hormone therapy in renal cell cancer.
Main Methods:
- Comprehensive literature review of studies on hormone receptors in renal cell cancer.
- Histochemical determination of estrogen receptors (ER) using monoclonal antibodies.
- Analysis of existing receptor assay data.
Main Results:
- The reviewed literature shows significant variability in results regarding hormone receptors in RCC.
- Our study utilized monoclonal antibodies for the histochemical determination of estrogen receptors.
- Existing data suggests a limited basis for current hormone therapy in renal cell cancer.
Conclusions:
- There is currently a very limited basis for applying hormone therapy in renal cell cancer.
- Conflicting results from receptor assays highlight the need for further investigation.
- New immunohistochemical methods are crucial to definitively resolve the question of hormone dependency in renal carcinoma.